Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2Skin Neoplasms 1Sarcoma, Kaposi 1Lymphoproliferative Disorders 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

VGX-3100 4Light Coagulation 3Watchful Waiting 2Polymerase Chain Reaction 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2Solutions 1Radiofrequency Ablation 1Observation 1Mindfulness-Based Stress Reduction 1Laser Therapy 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Histological Techniques 1Gene Expression Profiling 1Folic Acid 1Electroporation Therapies 1Data Collection 1DNA Methylation 1Blue Light 1Biopsy 1Aminolevulinic Acid 15-aminolaevulinic acid-n-pentylester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Squamous Intraepithelial Lesions × 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone × Clear all
NCT00285207 2010-10-11

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Tigris Pharmaceuticals

Phase 2 Completed
147 enrolled 6 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT00596258 2009-05-22

TG-003

Tigris Pharmaceuticals

Phase 2 Completed
11 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡